Teahose.
SIGN IN
NEW HERE — WHAT TEAHOSE DOES
We read the entire AI & tech firehose — so you don't have to.
PODPodcastsAll-In, No Priors, Acquired…
NEWNewslettersStratechery, Newcomer…
PAPPapersPhysical AI research
PHProduct Huntdaily launches
VCInvestor ScoutSequoia, a16z, Benchmark…
CLAUDE DISTILLS →
7 reads, 30 sec each — free, 6 AM ET.
+ a live graph of the companies, people & themes underneath.
HOME/PEOPLE/CREMIEUX RECUEIL
// PERSON

Cremieux Recueil

ROLE INDEPENDENT RESEARCHERMENTIONS 9LAST SEEN APRIL 29, 2026
// BIO

Independent researcher specializing in psychometrics, econometrics, and cliometrics, known for quantitative analysis of global biomedical trends.

// RECENT MENTIONS
// SIGNALS
9 SIGNALS
01
mention·The a16z Show·APRIL 29, 2026

China is actually ahead of the U.S. now. And I'm going to show you some documentation of that. Some people haven't realized it yet. It hasn't really leaked to the press at this point.

Source
02
mention·The a16z Show·APRIL 29, 2026

Eli Lilly has these two trials... they wanted to get the full placebo effect size. They have these two trials and what they both have the same inclusion criteria... your control arm for your novel thing, you don't have to actually have a control arm. Just use the control data from that previous trial.

Source
03
mention·The a16z Show·APRIL 29, 2026

Basically he finds drugs that have been abandoned and he looks at them and he goes, oh, this actually helped this like secondary endpoint. Let's go pick up that drug, buy it for cheap because it was abandoned. And then repurpose it for this other thing.

Source
04
mention·The a16z Show·APRIL 29, 2026

I think it'll be very good. You should actually invite the other guy who did the Dana Farber qui tam case on... one guy filed his own case against Dana-Farber for fake images and stuff. Sholto David.

Source
05
mention·The a16z Show·APRIL 29, 2026

Eliezer Masliah, the guy who used to run the NIA's neuroscience division, he was the top researcher globally on Alzheimer's and Parkinson's... And he basically led to the misallocation of billions of dollars in money.

Source
06
mention·The a16z Show·APRIL 29, 2026

It was either Amgen or Gilead did it first... then the actual price on the drug that is paid by the insurers, the net price, came down immediately. Because when you have like 10 drugs in a space, the cost of the drug is like 90% down.

Source
07
mention·The a16z Show·APRIL 29, 2026

He basically led to the misallocation of billions of dollars in money that went to like clinical trials and all this stuff... Tons of people spent time trying to replicate his stuff and it just did not work.

Source
08
mention·The a16z Show·APRIL 29, 2026

Basically he finds drugs that have been abandoned and he looks at them and he goes, oh, this actually helped this like secondary endpoint. Let's go pick up that drug, buy it for cheap because it was abandoned. And then repurpose it for this other thing.

Source
09
mention·The a16z Show·APRIL 29, 2026

He basically led to the misallocation of billions of dollars in money that went to like clinical trials and all this stuff... Tons of people spent time trying to replicate his stuff and it just did not work. So we went down like a tech tree that shouldn't exist.

Source

AI-extracted from podcast / newsletter / paper summaries. May contain errors.

Cremieux Recueil · Independent Researcher — 9 mentions on Teahose